Low Threshold Buprenorphine

Program Release: October 22, 2020
Expiration Date: October 22, 2022
Estimated time to complete: 30 Minutes
There are no prerequisites for participation.

Guest Speaker
Era Kryzhanovskaya, MD
Assistant Professor, Medicine
University of California, San Francisco School of Medicine
Chair, Controlled Substance Review Committee
UCSF Health | San Francisco, CA

Program Description
This module will review the principles and steps in starting a patient on buprenorphine same day as the visit.

Method of Participation and How to Receive CME Credit

There are no fees for participating in and receiving credit for this activity.

  • Review the activity objectives, faculty information, and CME information prior to participating in the activity.
  • View the CME presentations
  • Complete the CME activity evaluation at the conclusion of the activity in order to receive a credit certificate.

Faculty Disclosure

In accordance with the disclosure policy of the Brown University CME Office as well as standards set forth by the Accreditation Council on Continuing Medical Education (ACCME), speakers have been asked to disclose any relevant financial relationship with the manufacturers of any commercial products and/or provider of commercial services discussed in any educational presentation and with any commercial supporters or exhibitors of this activity.

The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation but to identified openly so that the listener may form his/her own opinion. Any potential conflicts of interest have been resolved prior to this presentation.

This activity may include discussion of off-label or investigative drugs uses. Speakers are aware that it is their responsibility to disclose to the audience this information. Individual Faculty Disclosure information may be found in the conference handouts.

Faculty Disclosure/Conflict of Interest

The following speaker and planning committee members have disclosed that they have no relevant financial relationships:
Speaker: Era Kryzhanovskaya, MD
Planning Committee Members: Rahul Vanjani, MD, MSc, Maria Sullivan

  • This project is supported by grant H79TI082570 from the Department of Health and Human Services/Substance Abuse and Mental Health Services Administration (SAMHSA)
  • This project is supported by grant 1H79TI082569-01 from the Department of Health and Human Services/Substance Abuse and Mental Health Services Administration (SAMHSA)
  • This project is supported by DOH01-CEIC-2019 from the New York State Department of Health Clinical Education Initiative: Hepatitis C and Drug User Health Center of Excellence
  • The contents provided are solely the responsibility of the authors and do not necessarily represent the official views of SAMSHA or Warren Alpert Medical School

Disclaimer and Privacy Policy

Privacy Policy: The Office of Continuing Medical Education (CME) and its educational partners protect the privacy of personal and other information regarding participants and educational collaborators. The CME Office maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. The CME Office will keep your personal information confidential when you participate in a CME Internet-based program. CME collects only the information necessary to provide you with the services that you request.

Disclaimer: This educational program is designed to present scientific information and opinion to Health professionals, to stimulate thought, and further investigation.

Target Audience

Physicians, Nurse Practitioners, Physician Assistants

Learning Objectives

At the conclusion of this session, attendees should be able to:

  1. Define low threshold buprenorphine initiation
  2. Describe the rationale for low threshold buprenorphine
  3. List three comp
Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
    The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 0.50 Attendance
    Participants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and AANP.
Course opens: 
10/16/2020
Course expires: 
10/22/2022
Cost:
$0.00
Rating: 
0

Accreditation
The Warren Alpert Medical School of Brown University is accredited by the ACCME to provide continuing medical education for physicians. 

Credit Designation
Physicians: The Warren Alpert Medical School of Brown University designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in this activity. 

Rhode Island Specific: This program qualifies for 0.5 hour CME Credit in Opioid Pain Management/Chronic Pain Management, one of the required areas of section 6.0; 6.2.1 Rhode Island CME re-licensure requirements.

Other Healthcare Professionals: Participants will receive a Certificate of Attendance stating this program is designated for 0.5 hours AMA PRA Category 1 Credits™. This credit is accepted by the AAPA and AANP.

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
    The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 0.50 Attendance
    Participants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and AANP.

Price

Cost:
$0.00
Please login or register to take this course.